Shang-Tao Chien
Overview
Explore the profile of Shang-Tao Chien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Huang S, Chang Y, Lin S, Lin W, Chen Y, et al.
Curr Issues Mol Biol
. 2023 Oct;
45(10):8013-8026.
PMID: 37886949
Concurrent chemoradiotherapy is an effective treatment option for patients with low-grade colorectal cancer (CRC) in the local disease stage. At present, the principle of the Taiwan Medical Center is to...
2.
Tsao D, Wang Y, Chien S, Lin S, Chang H
Pak J Pharm Sci
. 2023 Mar;
36(1):89-97.
PMID: 36967501
Development of adjuvant chemotherapy drugs against drug-resistant lung cancer cells is necessary. The use of non-toxic adjuvant natural product combined with chemotherapy drugs will be an important treatment mode in...
3.
Pan C, Wang S, Yen C, Zeng S, Kumur A, Liang S, et al.
J Nanosci Nanotechnol
. 2020 Mar;
20(8):5162-5174.
PMID: 32126717
This study aimed to develop emulsification assisted with ultrasonic atomization (EUA) to make embolic biodegradable poly(caprolactone) (PCL) spherical-microcarriers with uniform particle size for mass production which was used to cure...
4.
Chien S, Kumar A, Pandey S, Yen C, Wang S, Wen Z, et al.
Curr Pharm Des
. 2018 Nov;
24(32):3758-3766.
PMID: 30417777
Background: Cancer is one of the most debilitating diseases worldwide; even though advances in molecular and cellular biology have contributed to the decline of mortality associated with cancer, the procedure...
5.
Yang M, Chien S, Yang T, Lin S, Lee T, Hong Y
Oncol Lett
. 2017 Nov;
14(6):6632-6644.
PMID: 29181101
Chibby has been identified as a putative tumor suppressor and antagonist to β-catenin, thereby controlling the Wnt signaling pathway. Chibby is typically downregulated in numerous types of cancer and may...
6.
Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al.
Toxicol Appl Pharmacol
. 2016 Sep;
311:88-98.
PMID: 27678524
The objective was to investigate the upstream mechanisms of apoptosis which were triggered by a novel anti-microtubule drug, ABT-751, in hepatocellular carcinoma-derived Huh-7 cells. Effects of ABT-751 were evaluated by...
7.
Chao C, Tsai C, Wang Y, Liu Y, Chen J, Chang Y, et al.
Exp Biol Med (Maywood)
. 2016 May;
241(16):1834-43.
PMID: 27216599
Compared with conventional aortic cross-clamping, endovascular balloon occlusion (EBO) is a valuable strategy in unstable ruptured abdominal aorta aneurysm patients; however, it is unclear how long the balloon may remain...
8.
9.
Liao C, Tsai C, Kuo W, Ben R, Lin H, Lee C, et al.
BMC Nephrol
. 2016 Mar;
17:23.
PMID: 26932814
Background: Emphysematous cholecystitis is a rare variant of acute cholecystitis with a high mortality rate. The combination of emphysematous cholecystitis, liver abscess and pneumoperitoneum are even rarer. Herein we present...
10.
Liao C, Lee C, Tsai C, Hsueh C, Wang C, Chen I, et al.
Biomed Res Int
. 2016 Feb;
2015:840542.
PMID: 26858957
We would like to highlight the application of natural products to hepatocellular carcinoma (HCC). We will focus on the natural products known as flavonoids, which target this disease at different...